stockrow
Tuesday 3 November 2026
Export CNC’s income statement to Excel — free account
Centene Corporation
CNC Healthcare Healthcare Plans
Centene Corporation’s revenue for fiscal 2025 (year ended December 2025) was $194.8 billion, up 19.4% from fiscal 2024.
- Revenue
- +1.93%
- EPS
- +99.0%
- Free cash flow
- −437.4%
- Total debt
- −11.6%
Quarter to September 2026, against a year earlier
66.49
1.96
−2.86%
Follow CNC
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 20.93 |
P/S ratio |
0.10 | 0.08 | 0.16 | 0.15 | |
P/FCF ratio |
4.70 | 2.27 | 3.54 | 7.79 | |
P/Operating CF |
46.43 | 3.69 | 8.83 | (8.37) | |
P/B ratio |
1.01 | 0.75 | 1.40 | 1.38 | |
Price to Tangible BV |
4.35 | 2.56 | 4.17 | 4.14 | |
EV/Sales |
0.09 | 0.04 | 0.10 | 0.11 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 10.14 | |
EV/Operating CF |
3.41 | 1.10 | 2.13 | 4.80 | |
EV/FCF |
4.02 | 1.23 | 2.32 | 5.74 | |
Quick Ratio |
1.05 | 1.08 | 1.11 | 1.12 | |
Current Ratio |
1.10 | 1.12 | 1.15 | 1.16 | |
Net Debt/EBITDA |
2.06 | (3.41) | (7.31) | 1,005.50 | |
Debt/Assets |
22.67% | 20.17% | 19.40% | 19.60% | |
Debt/Equity |
0.87 | 0.76 | 0.71 | 0.70 | |
Asset Turnover |
2.45 | 2.36 | 2.40 | 2.53 | |
Operating CF/Net income |
(0.40) | 2.83 | 3.29 | 51.68 | |
Capex/Depreciation |
(0.65) | (0.67) | (0.58) | (0.65) | |
Interest Coverage |
(10.39) | 11.35 | 7.83 | (2.06) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6.78% | 6.80% | 5.79% | 6.39% | |
Intangible Assets out of Total Assets |
0.20 | 0.19 | 0.18 | 0.19 | |
Share Based Compensation of Revenue |
0.12% | 0.13% | 0.11% | 0.10% | |
Graham Net Nets |
(0.81) | (0.91) | (0.43) | (0.38) | |
Graham Number |
0.00 | 0.00 | 0.00 | 54.88 | |
Earnings Yield |
(33.07%) | (40.07%) | (16.20%) | 4.78% | |
Free Cash Flow Yield |
21.29% | 44.15% | 28.24% | 12.85% | |
Revenue per Share |
100.84 | 101.50 | 108.50 | 102.49 | |
Operating CF per Share |
0.89 | 8.87 | 7.27 | (7.42) | |
Capex per Share |
(0.43) | (0.41) | (0.35) | (0.39) | |
Free Cash Flow per Share |
0.45 | 8.47 | 6.92 | (7.82) | |
Cash per Share |
41.21 | 48.25 | 54.79 | 47.73 | |
Shareholders Equity per Share |
40.63 | 43.70 | 45.83 | 45.09 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
40.63 | 43.70 | 45.83 | 45.09 | |
Free Cash Flow |
224.00 | 4,166.00 | 3,416.00 | (3,863.00) | |
Working Capital |
3,652.00 | 4,944.00 | 5,926.00 | 6,393.00 | |
Capital Expenditures |
(213.00) | (200.00) | (174.00) | (194.00) | |
Net Current Asset Value |
(16,344.00) | (14,684.00) | (13,693.00) | (11,536.00) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 22.49 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 30.48 | |
| Other line items | |||||
Average Receivables |
18,909.00 | 20,931.00 | 19,814.00 | 21,719.00 | |
Average Payables |
13,485.00 | 15,390.00 | 15,742.50 | 16,167.00 | |
Average Assets |
79,596.00 | 84,109.50 | 84,703.50 | 80,683.50 | |
Average Common Equity |
23,266.50 | 24,754.50 | 25,063.00 | 21,657.50 |
Columns are period end dates · fundamentals updated 2 Nov 2026